Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Expanding access to hepatitis C virus care: a call to deconstruct individualized therapy.

Aronsohn A, Jensen D.

Hepatology. 2014 Jan;59(1):13-5. doi: 10.1002/hep.26590. Epub 2013 Oct 22. No abstract available.

PMID:
23788009
2.

Expanding access to treatment for HIV/HCV coinfected patients.

[No authors listed]

HRSA Careaction. 2006 Aug:1-12. No abstract available.

PMID:
16969925
3.

Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment.

Venegas M, Brahm J, Villanueva RA.

Ann Hepatol. 2012 Nov-Dec;11(6):827-37. Review.

4.

Hepatitis C virus infection: accessing drug treatment.

Smyth D, Webster D.

CMAJ. 2015 Oct 20;187(15):1113-4. doi: 10.1503/cmaj.150652. Epub 2015 Aug 24. No abstract available.

5.

Overcoming injustice: A roadmap to improve access to hepatitis C virus therapy for our medicaid patients.

Carter LDB, Aronsohn A.

Hepatology. 2017 May;65(5):1735-1740. doi: 10.1002/hep.29095. Epub 2017 Mar 31. No abstract available.

PMID:
28160311
6.

Regulators deny access to experimental hepatitis C drug.

Hillson G.

Can HIV AIDS Policy Law Rev. 2002 Dec;7(2-3):31-2. English, French.

PMID:
14719494
7.

Enhancing hepatitis C treatment in the custodial setting: a national roadmap.

Mina MM, Clark PJ, Beasley HM, Herawati L, Butler TG, Lloyd AR.

Med J Aust. 2014 Jan 20;200(1):15-6. No abstract available.

PMID:
24438398
8.

Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?

Grebely J, Haire B, Taylor LE, Macneill P, Litwin AH, Swan T, Byrne J, Levin J, Bruggmann P, Dore GJ; International Network for Hepatitis in Substance Users.

J Hepatol. 2015 Oct;63(4):779-82. doi: 10.1016/j.jhep.2015.06.014. Epub 2015 Aug 4. No abstract available.

PMID:
26254264
9.

[Revolution of hepatitis C antiviral therapy: when will Icelanders gain access to the new drugs?[Editorial]].

Ólafsson S.

Laeknabladid. 2015 Jun;101(6):295. Icelandic. No abstract available.

PMID:
26158532
10.

Newly acquired hepatitis C--many hurdles from diagnosis until treatment initiation.

Wiegand J.

J Gastroenterol Hepatol. 2008 Dec;23(12):1782-4. doi: 10.1111/j.1440-1746.2008.05698.x. No abstract available.

PMID:
19120870
11.

Hepatitis C virus (HCV) therapies special thematic issue: call for papers.

Georg GI, Wang S.

J Med Chem. 2013 Jan 24;56(2):387. doi: 10.1021/jm301895h. Epub 2013 Jan 7. No abstract available.

PMID:
23294104
12.

Current challenges in hepatitis C.

Swan T.

Res Initiat Treat Action. 2004 Fall;10(2):17-20. No abstract available.

PMID:
15828096
13.
14.

[Integrated treatment of hepatitis C among people with concurrent mental health and substance abuse disorders: promoting change in an urban area].

Chayer MC, Vieux MG, Bruneau J, Jutras-Aswad D.

Sante Ment Que. 2011 Autumn;36(2):77-96. French.

PMID:
22997647
15.

Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.

Roux P, Fugon L, Winnock M, Salmon-Céron D, Lacombe K, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO-13-HEPAVIH Study Group.

Addiction. 2012 Jan;107(1):152-9. doi: 10.1111/j.1360-0443.2011.03608.x. Epub 2011 Oct 12.

PMID:
21819472
16.

Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.

Bruggmann P.

J Viral Hepat. 2012 Dec;19(12):829-35. doi: 10.1111/jvh.12008. Epub 2012 Oct 1. Review.

PMID:
23205675
17.

Is the HCV pipeline heading in the right direction?

Aronsohn A, Muir AJ, Swan T, Jensen D.

Gastroenterology. 2013 Mar;144(3):482-5. doi: 10.1053/j.gastro.2013.01.018. Epub 2013 Jan 23. No abstract available.

PMID:
23352458
18.

[Current advances in hepatitis C treatment].

Cisneros-Garza LE.

Salud Publica Mex. 2011;53 Suppl 1:S52-60. Review. Spanish.

19.

Many eligible federal inmates won't get new hepatitis treatment.

Webster P.

CMAJ. 2016 May 17;188(8):E132. doi: 10.1503/cmaj.109-5252. Epub 2016 Mar 29. No abstract available.

20.

Predictors of antiviral therapy in a post-transfusion cohort of hepatitis C patients.

Witkos M, Yi QL, Heathcote J, Kapral MK, Krahn MD.

Can J Gastroenterol. 2006 Feb;20(2):107-11.

Supplemental Content

Support Center